A breakthrough in RF technology, BioFuse™ tissue welding, is engineered to replace sutures and staples while delivering faster, stronger, and more reliable surgical closure.
BioFuse™ is a next-generation RF tissue sealing and welding technology engineered to transform how surgeons achieve sealing and closure. By eliminating the need for traditional sutures and metal staples, BioFuse™ delivers a fast, precise, and leak-proof connection between tissues—supporting better outcomes and faster healing.
BioFuse™ creates a continuous, gap-free tissue seal—reducing the trauma, leak risk, and scarring associated with traditional closure methods.
Our proprietary RF algorithm continually adjusts in real-time (versus sampling), delivering consistent, controlled energy that adapts to tissue conditions during every procedure.
Validated in 1,000's of procedures in Europe, our original vessel sealer is 510(k) cleared and we're preparing to submit an updated 510(k) application for our present generator and hand piece.
Surgeons are seeking the next-generation solution that eliminates scarring, lowers infection rates, and supports evolving minimally invasive techniques.
BioFuse™ has a robust pipeline of future products, backed by strong IP protection with proprietary trade secrets. This isn’t just a device — it’s the foundation for a new era in surgical energy delivery for tissue welding.
Whether you’re a provider, investor or partner — we want to hear from you.
© BioFuse™ Medical Technologies, Inc. All Right Reserved 2025.
John “Bob” Roberts, MD, MBA
Board Member
-Board-certified thoracic surgeon specializing in minimally invasive thoracic surgery, including thoracoscopy, robotic surgery and other surgical treatments of lung and esophageal cancers
-Medical degrees with honors from Yale University and an MBA from Auburn University
-Medical staff of the Eugene M & Christine E. Lynn Cancer Institute and BocaCare® Physician Network at Boca Raton Regional Hospital
-Selected by his peers to the “Best Doctors in America” from 2003-2018.
Neil Hyman, MD
Board Member
-Expert in colon and rectal surgery. Specializes in the surgical treatment of gastrointestinal malignancies and inflammatory bowel disease
-Serves as Senior Examiner for the American Board of Colon and Rectal Surgery and as an Associate Examiner for the American Board of Surgery
-Authored more than 200 peer-reviewed original articles or textbook chapters and serves as a reviewer for numerous scientific publications.
-Consistently named to the list of Best Doctors in America by Best Doctors, Inc. and America’s Top Doctors for Cancer by Castle Connolly Medical Ltd
John Monson, MD
Chairman
-Executive Director of Colorectal Surgery at AdventHealth, Orlando
-Former chair of the U.K.’s National Training Program
-Advanced fellowship training at Mayo Clinic in surgical oncology, vascular surgery and colon and rectal surgery.
-Presented more than 1000 lectures around the world, authored 400+ original published papers, four books and more than 250 book chapters.
“For all surgeons, anastomotic leaking is the most dreaded of complications and continues to be the leading cause of post-operative mortality after colorectal surgery. It’s time for a new approach to creating the safest anastomosis.” -John Monson, M.D.
Tim Schmitt
Commercial Advisor
-US Air Force veteran with 25+ years in orthopedic and medical industries.
-Excelled in sales and senior leadership roles at Stryker Orthopedics.
-Trained surgeons on innovative procedures and technologies.
-Experienced in medical device product innovation and marketing.
Tariq Khurshid
Regulatory & QMS
-Over 20 years experience in medical device and pharmaceutical regulations for over 30 organizations including Medtronic, Zimmer, Boston Scientific, Hologic and Amazon Medical
-Specializes in FDA, EU MDR, ISO compliance, and premarket submissions, 510 (k) and PMA.
-Developed risk management frameworks and Quality Management Systems.
Rick Earley
President & CEO
-CEO & major investor in BioFuse
-Founder & former CEO MetPro Group
-Former shareholder Floeter Retort pouches,
acquired by Pro Ampac
Albert Juergens
Chief Technology Officer
-Extensive background in medical device & product development
-Experience in the development of electrosurgical generators
-Designed and cleared through FDA 510(k) 3 RF generators
-Holds 7 patents including two in electrosurgical generators
-Technical expertise includes electronic hardware, software and firmware as well as mechanical
and optical systems designs, all while navigating government regulatory & requirements
Frank D’Amelio
Senior Advisor
-30+ years of medical device experience with over 250 devices through the FDA
Previous Positions:
CEO, Epica International
President, Live Tissue Connect, Inc
Executive VP, CTO, Gyrus Corporation
Chief Manufacturing Officer, ACMI
Joseph Stauffer, DO, MBA
Chairman
-CEO/Founder, Delta Life Sciences, LLC
-Chief Medical Officer, Antibe Therapeutics
-Former Global Medical Director, Abbott Labs
-Former FDA Medical Review Officer in the Anti-Inflammatory & Analgesic Division of the Center for Drug Evaluation and Research
-U.S. Navy Veteran
Guy Hoagland, MD
Director
-Medical Doctor with certifications in Internal & Geriatric Medicine
-Has served as Medical Director and Chief Operating Officer of Southern Care, Inc bringing in to the top 5 hospice providers in the nation
Ernest Stern, J.D. LL.M
Director
Roland Austrup
Director
-Innventure appointee to BioFuse Board of Directors
-Chief Financial Officer, Innventure LLC
-Chairman of WaveFront Global Asset Management Corp
-Cofounder of Envest Corp
JP Palacio
Software & Technology Advisor
-CEO of Kromeon, a leading software and mobile app development company
-Partnered with high-profile clients like NFL, Nordstrom & Domino’s
-Expert in med tech and cross-industry innovation projects
-Specializes in scalable, user-centric digital solutions
Edwin Aguilera
Product & Manufacturing
-Founder of Nikao, Inc., pioneering innovative medical devices since 2020.
-Developed Neural-Enabled Prosthesis (NEP) to enhance prosthetic functionality.
-Experienced in business development and global manufacturing strategies.
-Expert in scaling operations and advancing medical technologies.
Randall Dull, MD, PhD
Medical Advisor
-Physician-executive, clinician-scientist and healthcare consultant
-Internationally recognized anesthesiologist
-NIH-funded Principle Investigator and recipients of two endowed chairs.
-Widely published in the area of vascular biology, endothelial signaling and endothelia permeability.
Michael Adler
VP, Business Development